BELgian ANtiCOagulation Survey for NVAF Patients
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Bayer
- 入组人数
- 164
- 试验地点
- 1
- 主要终点
- Age categories of patients
研究概览
简要总结
In this study researchers want to learn more about the patient's and treating doctor's concerns about possible bleedings during treatment with drugs preventing blood clots in blood vessels and the heart - so called blood thinner. The study also wants to find out more about the patient's knowledge on the importance, risks and benefits of treatment with this drug group.
Patients with irregular heartbeat not caused by valvular heart disease who will start treatment with a blood thinner will be asked by their treating cardiologist to complete a questionnaire related to their knowledge and fear of possible bleedings or stroke (blockage or rupture of a blood vessel to the brain) due to the intake of a blood thinner. The treating doctor will complete a similar questionnaire. The study plans to involve 15 cardiologists and 300 patients in Belgium.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Age categories of patients
时间窗: 1 day
Collected via the questionnaire.
Level of patients fear of having a stroke or thrombosis assessed by physicians on a scale from 0 - 10
时间窗: 1 day
Level of patients fear of having a stroke or thrombosis on a scale from 0 - 10
时间窗: 1 day
Patients' level of agreement with various statements of using NOACs in general
时间窗: 1 day
By using a 5-point Likert scale (completely disagree, more likely to disagree, no opinion, more likely to agree, completely agree)
Level of patients fear of having a bleeding on a scale from 0 - 10
时间窗: 1 day
Level of patients fear of having a bleeding assessed by physicans on a scale from 0 - 10
时间窗: 1 day
Gender (Female or male) of patients
时间窗: 1 day
Collected via the questionnaire.
Age categories of physicians
时间窗: 1 day
Collected via the questionnaire.
Gender (Female or male) of physicians
时间窗: 1 day
Collected via the questionnaire.
Physicans' level of agreement with various statement of using NOACs in general
时间窗: 1 day
By using a 5-point Likert scale (completely disagree, more likely to disagree, no opinion, more likely to agree, completely agree)
次要结局
未报告次要终点
